DYRK2 and central nervous system cancer: To summarize, a growing body of evidence suggests that DYRK2 is mainly involved in neuroblastoma, glioma, epilepsy, and neuroinflammation but also could be involved in traumatic and neurodegenerative diseases and Rabies virus infection.